Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-09-15 Sale |
2021-09-17 12:20 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
4,500 | $296.78 | $1,335,510 | 5,265 (Direct) |
View |
2021-06-07 Sale |
2021-06-09 2:03 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
4,500 | $266.56 | $1,199,520 | 9,737 (Direct) |
View |
2021-05-06 Sale |
2021-05-10 08:21 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
2,500 | $276.55 | $691,375 | 7,844 (Direct) |
View |
2021-05-03 Sale |
2021-05-05 10:48 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BELINGARD JEAN-LUC Director |
2,600 | $269.16 | $699,803 | 15,569 (Direct) |
View |
2021-03-30 Sale |
2021-04-01 08:32 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
667 | $251.88 | $168,004 | 5,006 (Direct) |
View |
2021-03-30 Sale |
2021-04-01 08:32 am |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
812 | $251.88 | $204,527 | 5,237 (Direct) |
View |
2021-02-18 Sale |
2021-02-19 2:17 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
2,317 | $241.51 | $559,589 | 7,024 (Direct) |
View |
2021-02-16 Sale |
2021-02-17 4:28 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
208 | $236.55 | $49,202 | 7,897 (Direct) |
View |
2021-02-16 Sale |
2021-02-17 4:27 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
188 | $237.06 | $44,567 | 18,130 (Direct) |
View |
2021-02-05 Sale |
2021-02-08 3:43 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
109 | $225.85 | $24,618 | 6,386 (Direct) |
View |
2021-02-05 Sale |
2021-02-08 3:40 pm |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
203 | $225.85 | $45,848 | 11,423 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-11-01 Exercise |
2021-11-03 11:49 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
9,024 | $0 | 59,635 (Direct) |
View |
2021-11-01 Tax Withholding |
2021-11-03 11:49 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
4,034 | $288.78 | 59,635 (Direct) |
View |
2021-11-01 Exercise |
2021-11-03 11:47 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
2,007 | $0 | 13,727 (Direct) |
View |
2021-11-01 Tax Withholding |
2021-11-03 11:47 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
898 | $288.78 | 13,727 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 12:20 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
4,500 | $84.86 | 5,265 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 12:20 pm |
2013-05-24 2022-05-23 |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
4,500 | $0 | 5,265 (Direct) |
View |
2021-08-02 Tax Withholding |
2021-08-03 4:16 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
15 | $297.61 | 2,628 (Direct) |
View |
2021-08-01 Exercise |
2021-08-03 4:16 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
50 | $0 | 2,628 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 2:03 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
4,500 | $84.86 | 9,737 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 2:03 pm |
2013-05-24 2022-05-23 |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
4,500 | $0 | 9,737 (Direct) |
View |
2021-05-03 Exercise |
2021-05-05 10:48 am |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BELINGARD JEAN-LUC Director |
2,600 | $98.49 | 15,569 (Direct) |
View |
2021-05-03 Exercise |
2021-05-05 10:48 am |
2012-05-11 2021-05-11 |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BELINGARD JEAN-LUC Director |
2,600 | $0 | 15,569 (Direct) |
View |
2021-04-03 Tax Withholding |
2021-04-06 12:18 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
452 | $252.67 | 17,125 (Direct) |
View |
2021-04-03 Exercise |
2021-04-06 12:18 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
1,010 | $0 | 17,125 (Direct) |
View |
2021-03-27 Tax Withholding |
2021-03-30 6:46 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
3,595 | $251.58 | 37,433 (Direct) |
View |
2021-03-27 Option Award |
2021-03-30 6:46 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
8,042 | $0 | 37,433 (Direct) |
View |
2021-03-27 Tax Withholding |
2021-03-30 6:45 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
1,079 | $251.58 | 14,186 (Direct) |
View |
2021-03-27 Option Award |
2021-03-30 6:45 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
2,413 | $0 | 14,186 (Direct) |
View |
2021-03-27 Tax Withholding |
2021-03-30 6:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
1,079 | $251.58 | 8,001 (Direct) |
View |
2021-03-27 Option Award |
2021-03-30 6:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
2,413 | $0 | 8,001 (Direct) |
View |
2021-03-27 Tax Withholding |
2021-03-30 6:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
790 | $251.58 | 9,786 (Direct) |
View |
2021-03-27 Option Award |
2021-03-30 6:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
2,104 | $0 | 9,786 (Direct) |
View |
2021-03-27 Tax Withholding |
2021-03-30 6:41 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
1,079 | $251.58 | 5,673 (Direct) |
View |
2021-03-27 Option Award |
2021-03-30 6:41 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
2,413 | $0 | 5,673 (Direct) |
View |
2021-03-27 Tax Withholding |
2021-03-30 6:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
687 | $251.58 | 6,049 (Direct) |
View |
2021-03-27 Option Award |
2021-03-30 6:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
2,310 | $0 | 6,049 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 12:15 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wengel Kathryn E Director |
603 | $0 | 603 (Direct) |
View |
2021-02-18 Exercise |
2021-02-19 2:17 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
1,533 | $146.59 | 7,024 (Direct) |
View |
2021-02-12 Tax Withholding |
2021-02-19 2:17 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
263 | $238.26 | 7,024 (Direct) |
View |
2021-02-12 Exercise |
2021-02-19 2:17 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
3,033 | $0 | 7,024 (Direct) |
View |
2021-02-18 Exercise |
2021-02-19 2:17 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
633 | $182.51 | 7,024 (Direct) |
View |
2021-02-12 Tax Withholding |
2021-02-17 4:28 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
158 | $238.26 | 7,897 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 4:28 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
573 | $0 | 7,897 (Direct) |
View |
2021-02-12 Tax Withholding |
2021-02-17 4:27 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
142 | $238.26 | 18,130 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 4:27 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
517 | $0 | 18,130 (Direct) |
View |
2021-02-12 Tax Withholding |
2021-02-17 4:25 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
180 | $238.26 | 24,371 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 4:25 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
581 | $0 | 24,371 (Direct) |
View |
2021-02-12 Tax Withholding |
2021-02-17 4:23 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
512 | $238.26 | 86,398 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 4:23 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
1,720 | $0 | 86,398 (Direct) |
View |
2021-02-12 Tax Withholding |
2021-02-17 4:22 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
854 | $238.26 | 38,980 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 4:22 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
2,870 | $0 | 38,980 (Direct) |
View |
2021-02-12 Tax Withholding |
2021-02-17 4:21 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
873 | $238.26 | 28,946 (Direct) |
View |
2021-02-12 Exercise |
2021-02-17 4:21 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
2,940 | $0 | 28,946 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:48 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schechter Adam H President & CEO |
1,028 | $223.78 | 30,636 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:48 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schechter Adam H President & CEO |
3,506 | $0 | 30,636 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:46 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
53 | $223.78 | 3,057 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:46 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Wilkinson Peter J SVP, Chief Accounting Officer |
150 | $0 | 3,057 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
83 | $223.78 | 6,386 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:43 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | van der Vaart Sandra D EVP, Chief Legal Officer |
300 | $0 | 6,386 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Summy Amy B. EVP, Chief Marketing Officer |
94 | $223.78 | 2,706 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:42 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Summy Amy B. EVP, Chief Marketing Officer |
266 | $0 | 2,706 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
154 | $223.78 | 11,423 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:40 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Schroeder Mark S EVP, President-Diagnostics Lab |
560 | $0 | 11,423 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:39 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
187 | $223.78 | 16,443 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:39 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Kirchgraber Paul R CEO, Covance Drug Development |
560 | $0 | 16,443 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:36 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
306 | $223.78 | 59,734 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:36 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | EISENBERG GLENN A Chief Financial Officer, EVP |
970 | $0 | 59,734 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:35 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
190 | $223.78 | 16,629 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:35 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Caveney Brian J EVP, President of Diagnostics |
560 | $0 | 16,629 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:34 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
131 | $223.78 | 18,070 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:34 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BERBERIAN LANCE EVP, CIO & CTO |
373 | $0 | 18,070 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:33 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Seltz Judith C EVP, CHRO |
96 | $223.78 | 2,135 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:33 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Seltz Judith C EVP, CHRO |
280 | $0 | 2,135 (Direct) |
View |
2021-02-04 Tax Withholding |
2021-02-08 3:14 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BELINGARD JEAN-LUC Director |
99 | $223.78 | 16,340 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:14 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | BELINGARD JEAN-LUC Director |
986 | $0 | 16,340 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 3:00 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Williams R Sanders Director |
986 | $0 | 7,003 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 2:59 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | Parham Richelle P Director |
986 | $0 | 6,845 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 2:58 pm |
N/A N/A |
LABORATORY CORP OF AMERICA HOLDINGS | LH | NEUPERT PETER M Director |
986 | $0 | 11,753 (Direct) |
View |